Literature DB >> 16530863

Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study.

Emanuela Rasini1, Marco Cosentino, Franca Marino, Massimiliano Legnaro, Marco Ferrari, Luigina Guasti, Achille Venco, Sergio Lecchini.   

Abstract

The renin-angiotensin system plays a key role in the regulation of cardiovascular functions and in particular angiotensin II type 1 receptor (AT1R)-operated pathways are involved in the modulation of inflammation in the vascular wall. In the present study we assessed the pattern of expression of AT1Rs on different human circulating leukocyte subsets. Venous blood was obtained from healthy male subjects. Leukocyte subsets were purified by immunomagnetic cell sorting or identified in whole blood using multiparametric cytometric analysis. RT-PCR analysis showed that AT1R mRNA was expressed in polymorphonuclear leukocytes (PMNs), monocytes, B-lymphocytes, and, to a lesser extent, T-lymphocytes. Flow cytometric analysis revealed that the frequency of expression of AT1Rs was: PMNs>monocytes>or=B-lymphocytes>>T-lymphocytes, while receptor density per positive cells was: PMNs>or=B-lymphocytes>T-lymphocytes>or=monocytes. AT1Rs are expressed on PMNs, monocytes, T- and B-lymphocytes, however the expression pattern is peculiar to each subset, possibly suggesting distinct roles in the various cell types. Investigating the expression and the functional role of AT1Rs on circulating leukocyte subsets, as well as their possible modifications in disease conditions before and after pharmacological treatments, is likely to provide novel clues to the comprehension of the mechanisms involved in the therapeutic efficacy of currently available agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530863     DOI: 10.1016/j.regpep.2006.01.007

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  16 in total

1.  Angiotensin II sustains brain inflammation in mice via TGF-beta.

Authors:  Tobias V Lanz; Zhaoqing Ding; Peggy P Ho; Jian Luo; Ankur N Agrawal; Hrishikesh Srinagesh; Robert Axtell; Hui Zhang; Michael Platten; Tony Wyss-Coray; Lawrence Steinman
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

2.  Angiotensin II enhances bacterial clearance via myeloid signaling in a murine sepsis model.

Authors:  Daniel E Leisman; Jamie R Privratsky; Jake R Lehman; Mabel N Abraham; Omar Y Yaipan; Mariana R Brewer; Ana Nedeljkovic-Kurepa; Christine C Capone; Tiago D Fernandes; Robert Griffiths; William J Stein; Marcia B Goldberg; Steven D Crowley; Rinaldo Bellomo; Clifford S Deutschman; Matthew D Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-15       Impact factor: 12.779

3.  Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.

Authors:  Johan H Gibcus; Lu Ping Tan; Geert Harms; Rikst Nynke Schakel; Debora de Jong; Tjasso Blokzijl; Peter Möller; Sibrand Poppema; Bart-Jan Kroesen; Anke van den Berg
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

4.  Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys.

Authors:  William B Strawn; Carlos M Ferrario
Journal:  Atherosclerosis       Date:  2007-08-09       Impact factor: 5.162

5.  Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity.

Authors:  Ariela Benigni; Silvia Orisio; Marina Noris; Paraskevas Iatropoulos; Davide Castaldi; Kei Kamide; Hiromi Rakugi; Yasumichi Arai; Marta Todeschini; Giulia Ogliari; Enyu Imai; Yasuyuki Gondo; Nobuyoshi Hirose; Daniela Mari; Giuseppe Remuzzi
Journal:  Age (Dordr)       Date:  2012-05-09

6.  Angiotensin II receptor expression and relation to Helicobacter pylori-infection in the stomach of the Mongolian gerbil.

Authors:  Peter Hallersund; Herbert F Helander; Anna Casselbrant; Anders Edebo; Lars Fändriks; Anders Elfvin
Journal:  BMC Gastroenterol       Date:  2010-01-14       Impact factor: 3.067

Review 7.  RAAS: A Convergent Player in Ischemic Heart Failure and Cancer.

Authors:  Texali C Garcia-Garduño; Jorge R Padilla-Gutierrez; Diego Cambrón-Mora; Yeminia Valle
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

8.  Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease.

Authors:  Saori Yaguchi; Yoko Ogawa; Shigeto Shimmura; Tetsuya Kawakita; Shin Hatou; Shingo Satofuka; Shigeru Nakamura; Toshihiro Imada; Hideyuki Miyashita; Satoru Yoshida; Tomonori Yaguchi; Yoko Ozawa; Takehiko Mori; Shinichiro Okamoto; Yutaka Kawakami; Susumu Ishida; Kazuo Tsubota
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

9.  Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment.

Authors:  Franca Marino; Andrea Maria Maresca; Marco Cosentino; Luana Castiglioni; Emanuela Rasini; Christian Mongiardi; Ramona C Maio; Massimiliano Legnaro; Laura Schembri; Francesco Dentali; Anna Maria Grandi; Luigina Guasti
Journal:  Cardiovasc Diabetol       Date:  2012-12-22       Impact factor: 9.951

10.  Angiotensin type 1a receptor signaling is not necessary for the production of reactive oxygen species in polymorphonuclear leukocytes.

Authors:  Fumiko Yamato; Junji Takaya; Shoji Tsuji; Masafumi Hasui; Kazunari Kaneko
Journal:  ISRN Inflamm       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.